Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Atlas Health Capital has completed the acquisition of its debut healthcare services other fund, a private equity vehicle in the UK, for $400m. Atlas Health Capital acquisitions are focused on healthcare services other businesses, targeting providers and operators that can expand capacity and improve care delivery across European markets. The healthcare M&A strategy centers on building a portfolio of healthcare services other platforms in the UK to support growth through operational improvements and add-on investments. As a private equity acquisition, the oversubscribed fund reached its £400m hard cap and is positioned as a platform for future healthcare services other acquisition activity, with final terms and closing details not publicly specified.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026